Mascha Binder

30PUBLICATIONS
146CO-AUTHORS
Molecular targetsInnate immunitySolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 14, 2026
Toward precision immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma: lessons from the FOCUS trial.

|Jun 05, 2026
Cytotoxic CD39<sup>+</sup> tumor-associated NK cells respond to NKG2A blockade in lung cancer.

|Apr 13, 2026
Dominant-negative PSMB10 disrupts immunoproteasome assembly and leads to transient T lymphopenia.

Sujal Ghosh, Yuqin Wang, Christoph Schultheiss

|Feb 12, 2026
Tertiary lymphoid structures: prognostic insights and implications for immunotherapy in HPV-negative head and neck cancer.

Tobias Andermatt, Christoph Schultheiss, Mascha Binder

|Feb 09, 2026
Cell Therapies and Bispecific Engagers: Redefining Strategies against Checkpoint Resistance.

Heinz Läubli, David König, Marco Donia

|Jan 05, 2026
High pretreatment peripheral blood T-cell receptor clonality as a predictor of prolonged response in immune thrombocytopenia.

Paul Schmidt-Barbo, Christoph Schultheiss, Annaïse J Jauch

Pageof 5

Frequent Collaborators

20 joint publications

Christoph Schultheiß

11 joint publications

Lisa Paschold

8 joint publications

Edith Willscher

4 joint publications

Heinz Läubli